Abstract:Dermatologic TherapyVolume 35, Issue 12 e15944 LETTER Leucocytoclastic vasculitis-like reaction induced by tocilizumab in a patient with rheumatoid arthritis Yu-Qing Hu, Yu-Qing Hu orcid.org/0000-0002-6282-6436 Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXue Chen, Xue Chen Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJian-Zhong Zhang, Corresponding Author Jian-Zhong Zhang [email protected] orcid.org/0000-0002-5485-682X Department of Dermatology, Peking University People's Hospital, Beijing, China Correspondence Jian-Zhong Zhang, No. 11 South Avenue, Xi Zhi Men Street, Xicheng District, Beijing 100044, China. Email: [email protected]Search for more papers by this author Yu-Qing Hu, Yu-Qing Hu orcid.org/0000-0002-6282-6436 Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXue Chen, Xue Chen Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJian-Zhong Zhang, Corresponding Author Jian-Zhong Zhang [email protected] orcid.org/0000-0002-5485-682X Department of Dermatology, Peking University People's Hospital, Beijing, China Correspondence Jian-Zhong Zhang, No. 11 South Avenue, Xi Zhi Men Street, Xicheng District, Beijing 100044, China. Email: [email protected]Search for more papers by this author First published: 18 October 2022 https://doi.org/10.1111/dth.15944 Funding information: National Natural Science Foundation of China, Grant/Award Number: 82103711 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Choong DJ, Tan E. Does tocilizumab have a role in dermatology? A review of clinical applications, its adverse side effects and practical considerations. Dermatol Ther. 2021; 34(4):e14990. 2Schlapbach C, Navarini AA. The continuing evolution of targeted therapy for inflammatory skin disease. Semin Immunopathol. 2016; 38(1): 123-133. 3Palmou-Fontana N, Sanchez Gavino JA, McGonagle D, Garcia-Martinez E, Iniguez de Onzono Martin L. Tocilizumab-induced psoriasiform rash in rheumatoid arthritis. Dermatology. 2014; 228(4): 311-313. 4Yoshiki R, Nakamura M, Tokura Y. Drug eruption induced by IL-6 receptor inhibitor tocilizumab. J Eur Acad Dermatol Venereol. 2010; 24(4): 495-496. 5Mori T, Yamamoto T. Tocilizumab-induced pustular drug eruption. Int J Rheum Dis. 2017; 20(11): 1776-1777. 6Sakaue S, Sumitomo S, Kubo K, Fujio K, Yamamoto K. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis. Rheumatology (Oxford). 2014; 53(8): 1529-1530. 7Khan M, Madi MY, Rencic J. Apixaban-induced cutaneous leucocytoclastic vasculitis. BMJ Case Rep. 2020; 13(8):e237043. 8Giorgio V, Blasi E, Rigante D, et al. Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report. Int J Environ Res Public Health. 2021; 18(13):6711. 9Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008; 112(10): 3959-3964. Volume35, Issue12December 2022e15944 ReferencesRelatedInformation

Interferon-gamma-induced local leukocytoclastic vasculitis at the subcutaneous injection site

Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration

Analysis of Adverse Effects of Infliximab Treatment in 486 Patients with Crohn′s Disease

Anaphylactic Shock and Severe Acute Urticaria Induced by Intramuscular Injection of Recombinant Human Interferon-Α1b

Alpha-interferon-induced arthritis: clinical presentation treatment, and prevention

Pegylated-interferon alpha (PEG-IFNα)-induced interstitial lung disease in a patient with chronic hepatitis B: A case report and literature review

Possible Terbinafine and/or Itraconazole Induced Vasculitis - A Case Study

Case report: Envafolimab causes local skin necrosis

Vasculitis‐like herpes zoster in the course of treatment with tofacitinib in ulcerative colitis: An assessment of local viral distribution by RNA in situ hybridization

Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report

Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome: A case report

Real-world data on the effectiveness and safety of interferon-alpha-2a intralesional injection for the treatment of focally recalcitrant mycosis fungoides

Leucocytoclastic Vasculitis‐like Reaction Induced by Tocilizumab in a Patient with Rheumatoid Arthritis

CPC04 An atypical case of vasculitis: when immunosuppression is not the answer

Severe Recalcitrant Necrotizing Leucocytoclastic Vasculitis in Non-Hodgkin's Lymphoma Associated with Hepatitis C: Successful Treatment with the Combination of Antiviral and Immunosuppressive Therapy

Interferon gamma as a trigger of chronic viral infections and inflammatory dermatoses

Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis

Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report

Rheumatoid arthritis induced by alpha-interferon therapy

The clincial analysis of 7 ankylosing spondylitis patients with adverse cutaneous reactions to infliximab

Targeting the Elevated IFN-γ in Vitiligo Patients by Human Anti- IFN-γ Monoclonal Antibody Hampers Direct Cytototoxicity in Melanocyte